Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Commercial
Deals
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Deals
Deals
Bayer, Bristol-Myers Squibb and Ono Pharma Team on Colorectal Cancer
Biospace News
-
July 18, 2019
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Biospace News
-
July 18, 2019
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part...
Biospace News
-
July 18, 2019
0
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data...
Firstwordpharma News
-
July 18, 2019
0
Deals
Spring Bank Announces Research Agreement with The National Institute of Allergy...
Firstwordpharma News
-
July 18, 2019
0
Deals
Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a...
Biospace News
-
July 17, 2019
0
Deals
Alnylam and 23andMe Collaborate on +MyFamily Program to Increase Awareness of...
Biospace News
-
July 16, 2019
0
1
2
3
...
78
Page 1 of 78
- Advertisement -
LATEST NEWS
DURECT Announces Patient Dosing in Phase 2a Proof-of-Concept Clinical Trial of Topical DUR-928 in Patients with Mild to Moderate Plaque Psoriasis
Biospace News
-
March 21, 2019
0
New Antimicrobials One of the Potential Solutions to Resistant Superbugs – WHO
May 23, 2019
Nivolumab with ipilimumab: drug combination has added benefit in advanced renal cell carcinoma
May 17, 2019
MUST READ
Polyphor Announces Presentation of New Survival Data on Balixafortide at the ASCO Annual Meeting...
Biospace News
-
May 20, 2019
0
Scottish Medicines Consortium cariprazine (Reagila)
Firstwordpharma News
-
May 13, 2019
0
Drug Prices Based On Success Could Speed Up Cancer Patients’ Treatment
Firstwordpharma News
-
February 21, 2019
0
Load more
